SCI Pharmtech Statistics

Total Valuation

SCI Pharmtech has a market cap or net worth of TWD 10.82 billion. The enterprise value is 11.03 billion.

Market Cap	10.82B
Enterprise Value	11.03B

Important Dates

The next estimated earnings date is Friday, November 8, 2024.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	Jul 1, 2024

Share Statistics

SCI Pharmtech has 119.51 million shares outstanding. The number of shares has increased by 7.55% in one year.

Shares Outstanding	119.51M
Shares Change (YoY)	+7.55%
Shares Change (QoQ)	-0.12%
Owned by Insiders (%)	6.58%
Owned by Institutions (%)	3.82%
Float	68.67M

Valuation Ratios

The trailing PE ratio is 75.89.

PE Ratio	75.89
Forward PE	n/a
PS Ratio	8.34
PB Ratio	2.14
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 34.69, with an EV/FCF ratio of -13.94.

EV / Earnings	79.68
EV / Sales	8.81
EV / EBITDA	34.69
EV / EBIT	87.49
EV / FCF	-13.94

Financial Position

The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.22.

Current Ratio	2.59
Quick Ratio	1.65
Debt / Equity	0.22
Debt / EBITDA	3.35
Debt / FCF	-1.43
Interest Coverage	26.16

Financial Efficiency

Return on equity (ROE) is 3.02% and return on invested capital (ROIC) is 1.65%.

Return on Equity (ROE)	3.02%
Return on Assets (ROA)	1.48%
Return on Capital (ROIC)	1.65%
Revenue Per Employee	5.24M
Profits Per Employee	579,360
Employee Count	239
Asset Turnover	0.20
Inventory Turnover	1.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.01% in the last 52 weeks. The beta is -0.21, so SCI Pharmtech's price volatility has been lower than the market average.

Beta (5Y)	-0.21
52-Week Price Change	-5.01%
50-Day Moving Average	89.16
200-Day Moving Average	90.98
Relative Strength Index (RSI)	50.80
Average Volume (20 Days)	102,445

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SCI Pharmtech had revenue of TWD 1.25 billion and earned 138.47 million in profits. Earnings per share was 1.19.

Revenue	1.25B
Gross Profit	347.37M
Operating Income	145.27M
Pretax Income	152.39M
Net Income	138.47M
EBITDA	335.13M
EBIT	145.27M
Earnings Per Share (EPS)	1.19

Full Income Statement

Balance Sheet

The company has 911.46 million in cash and 1.13 billion in debt, giving a net cash position of -217.05 million or -1.82 per share.

Cash & Cash Equivalents	911.46M
Total Debt	1.13B
Net Cash	-217.05M
Net Cash Per Share	-1.82
Equity (Book Value)	5.05B
Book Value Per Share	42.26
Working Capital	1.24B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 105.52 million and capital expenditures -896.93 million, giving a free cash flow of -791.41 million.

Operating Cash Flow	105.52M
Capital Expenditures	-896.93M
Free Cash Flow	-791.41M
FCF Per Share	-6.62

Full Cash Flow Statement

Margins

Gross margin is 27.75%, with operating and profit margins of 11.60% and 11.06%.

Gross Margin	27.75%
Operating Margin	11.60%
Pretax Margin	12.17%
Profit Margin	11.06%
EBITDA Margin	26.77%
EBIT Margin	11.60%
FCF Margin	-63.22%

Dividends & Yields

This stock pays an annual dividend of 1.25, which amounts to a dividend yield of 1.37%.

Dividend Per Share	1.25
Dividend Yield	1.37%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	17.22%
Buyback Yield	-7.55%
Shareholder Yield	-6.18%
Earnings Yield	1.32%
FCF Yield	-7.32%

Dividend Details

Stock Splits

The last stock split was on July 27, 2023. It was a forward split with a ratio of 1.125.

Last Split Date	Jul 27, 2023
Split Type	Forward
Split Ratio	1.125

Scores

SCI Pharmtech has an Altman Z-Score of 4.43.

Altman Z-Score	4.43
Piotroski F-Score	n/a